Medical News and Alerts

Diazepam Nasal Spray (Valtoco®) Updates

November 24, 2020
Diazepam Nasal Spray (Valtoco®) Updates
 Earlier this year, Valtoco (diazepam nasal spray) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizure clusters and acute repetitive seizures. The makers of Valtoco have recently announced that it will now be available in pharmacies nationwide. Read the full press release from Neurelis, Inc. here.
Valtoco is currently approved for adult and pediatric patients six years of age and older. If you have questions about this medicine, please email info@neurelis.com 

Related Posts

Recall – Vigabatrin for Oral Solution USP

Recall – Vigabatrin for Oral Solution USP

by | Dec 12, 2023

TOPIC: Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals: Recall - Due to Leaking Sachets AUDIENCE: Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE: InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for Oral...

FDA Warns of Rare but Serious Drug Reaction

FDA Warns of Rare but Serious Drug Reaction

by | Dec 4, 2023

The Dup15q Alliance is aware of the recent release by the FDA regarding Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam) warning about the risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This adverse event is...

Medication Recall Alert Sabril® (Vigabatrin)

Medication Recall Alert Sabril® (Vigabatrin)

by | Sep 7, 2023

Our friends at the Epielpsy Foundation have shared the Following Medication Recall The company that makes Sabril® (vigabatrin) for oral solution, a prescription medication to manage seizures in children and adults, has announced a recall of this medication because of...